¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Blue Cross Association research series."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • series elastic component
    Á÷¿­Åº·Â¼ººÐ
  • series limit
    °è¿­±ØÇÑ
  • alkali blue
    ¾ËÄ®¸®Ã»
  • blue
    û»ö, ÆÄ¶û
  • blue asphyxia
    û»öÁú½Ä
  • blue baby
    û»ö¾Æ
  • blue disease
    û»öº´
  • blue drum
    û»ö°í¸·
  • blue gum
    û»öÀÕ¸ö, û»öÄ¡Àº
  • blue jaundice
    ûȲ´Þ
  • blue line
    û»ö¼±
  • blue nevus
    û»ö¸ð¹Ý
  • blue pus
    û»ö°í¸§
  • blue rubber bleb nevi
    û»ö°í¹«¹°Áý¸ð¹Ý, û»ö°í¹«°Åǰ¸ð¹Ý
  • blue sclera
    û»ö°ø¸·
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hypergeometric series
    ÃʱâÇϱ޼ö
  • ionization series
    ÀÌ¿ÂÈ­°è¿­
  • lymphocyte series
    ¸²ÇÁ±¸°è¿­
  • lyotropic ionic series
    À̾×À̿°迭
  • series limit
    °è¿­, ±ØÇÑ
  • series
    °è¿­, ±Þ¼ö
  • alkali blue
    ¾ËÄ®¸®Ã»
  • blue asphyxia
    û»öÁú½Ä
  • blue
    ÆÄ¶õ»ö, ºí·ç
  • blue baby
    û»ö¾Æ
  • blue disease
    û»öº´
  • blue drum
    û»ö°í¸·
  • blue gum
    û»öÄ¡À°, û»öÀÕ¸ö
  • blue jaundice
    ûȲ´Þ
  • blue line
    (¢¡lead line) ³³¼±
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • homologous series
    µ¿Á·°è¿­(¡­Í§æê).
  • hypergeometric series
    ÃʱâÇϱ޼ö(̧˻̰˻Ëà).
  • principal series
    ÁÖ°è¿­(̡˭Ëç).
  • Alician blue stain
    ¾Ë¸®¼¢ ºí·ç ¿°»ö
  • BPB=£¾bromphenol blue
    ºê·ÒÆä³îû.
  • EMB => eosin methylene blue
    ¿¡¿À½Å¸ÞÆ¿·»ºÒ·ç
  • Evans blue
    ¿¡¹Ý½ºÃ»(ôì).
  • Evans blue
    ¿¡¹Ý½ºÃ».
  • alcian blue
    ¾Ë½Ã¾Èºí·ç
  • hydrone blue
    È÷µå·Ðû(¡­ôì).
  • indophenol blue
    ÀεµÆä³îû(¡­ôì).
  • polychrome methylene blue
    ´Ù»ö¸ÞÆ¿·»ºí·ç
  • prussian blue reaction
    °¨Ã»¹ÝÀÀ
  • Cross bridge
    ±³Â÷°áÇÕ(Îßó©Ì¿ùê), ¿¬°á±³
  • Cross bridge cycle
    ±³Â÷°áÇÕÁÖ±â(Îßó©Ì¿ùêñÎÑ¢)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • discrete series
    ºÒ¿¬¼Ó¼ö¿­(ËÓËçËÛËàËç).
  • exponential series
    Áö¼ö±Þ¼ö(ÊÙË»Ëà).
  • gallbladder series
    ´ã³¶Á¶¿µ°Ë»ç.
  • gallbladder series
    ´ã³²Á¶¿µ°Ë»ç
  • homologous series
    µ¿Á·°è¿­(¡­Í§æê).
  • hypergeometric series
    ÃʱâÇϱ޼ö(̧˻̰˻Ëà).
  • ionization series
    ÀÌ¿ÂÈ­°è¿­.
  • lymphoid cell series
    ¸²ÇÁ¼¼Æ÷°è.
  • lyotropic ionic series
    À̾×À̿°迭(¡­Í§æê).
  • principal series
    ÁÖ°è¿­(̡˭Ëç).
  • series elastic component
    Á÷·Äź·Â¼ººÐ(òÁ æê÷¥æ³à÷ÝÂ).
  • series elastic element
    Á÷·Äź¼º¿ä¼Ò (¡­é©áÈ).
  • series limit
    °è¿­(Ë­Ëç), ±ØÇÑ(˻̰).
  • subsidiary series
    ºÎ°è¿­(Üùͧæê).
  • time series analysis
    ½Ã°£º°ºÐ¼®
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • naphthol blue black
    ³ªÇÁÅç ºÒ·ç ºÒ·¢
  • chaotropic series
    ¹«Áú¼­(Ùíòñßí) ¾¾¸®½º
  • decay series
    "ºØ±« °è¿­(ÝÚÎÕ֪ͧ), (µ¿) radioactive series"
  • eluotropic series
    ¿ë¸® ¼­¿­ (éÁ×îßíÖª)
  • globo-series glycosphingolipids
    ±Û·Îº¸°è¿­(֪ͧ) ´ç(ÓØ)½ºÇΰíÁöÁú(ò·òõ)
  • Hofmeister series
    È£ÇÁ¸¶À̽ºÅÍ °è¿­(֪ͧ)
  • homologous series
    µ¿Á· °è¿­(ÔÒðé֪ͧ)
  • lacto-series glycosphingolipid
    ¶ôÅä°è¿­(֪ͧ) ±Û¶óÀÌÄÚ½ºÇΰíÁöÁú(ò·òõ)
  • lyotropic series
    À̾װ迭(ìÆäû֪ͧ)
  • radioactive series
    ¹æ»ç¼º °è¿­(Û¯ÞÒàõ֪ͧ)
  • Trappe's eluotropic series
    Æ®¶óÆä ¿ë¸®¼­¿­(éÁ×îßíÖª)
  • absorption cross-section
    Èí¼ö ´Ü¸éÀû (ýå⥠ӨØüîÝ)
  • cross
    "±³Â÷(Îßó©), ±³Àâ(ÎßíÚ), ±³ÀâÁ¾(ÎßíÚðú)"
  • cross-absorption
    ±³Â÷Èí¼ö(Îßó©ýåâ¥)
  • cross-agglutination test
    ±³Â÷ÀÀÁý °Ë»ç(Îßó©ëêó¢ËþÞÛ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BCA balloon catheter angioplasty; bicinchoninic acid; blood color analyzer; Blue Cross Association; bran...
AAP air at atmospheric pressure; American Academy of Pediatrics; American Academy of Pedodontics; Americ...
IPA immunoperoxidase assay; incontinentia pigmenti achromians; independent physician or practice associa...
BC Bachelor of Surgery [Lat. Baccal-aureus Chirurgiae]; back care; bactericidal concentration; basal ce...
BIP bacterial intravenous protein; biparietal; bismuth iodoform paraffin; Blue Cross interim payment; br...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CSA Cross sectional areas
CCF Cross-correlation functions
CCH Cross-correlation histograms
CMM Cross-modality matching
CP Cross-polarization
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • American Heart Association
    ¹Ì±¹½ÉÀ庴ÇÐȸ, ¹Ì±¹½ÉÀåÇÐȸ
  • American Medical Association Guides to the Evaluation of Permanent Impairment
    ¿µ±¸¼Õ»óÀÇ Æò°¡¸¦ À§ÇÑ ¹Ì±¹ ÀÇÇÐÇùȸÀÇ Áöħ¼­
  • American Rheumatism Association
    ¹Ì±¹ ·ù¸¶Æ¼Áò Çùȸ
  • association area
    ¿¬ÇÕ ±¸¿ª, ¿¬ÇÕ¾ß, ¿¬ÇÕ ¿µ¿ª
    ´ë³ú ÇÇÁúÀÇ °¢¸éÀ¸·Î¼­ ³ú·®°ú ³ú¹Ý±¸ÀÇ ¹éÁúÀ» Åë°úÇÏ´Â ¸¹Àº ¼¶À¯¿¡ ÀÇÇØ ¿¬°áµÇ°í ½Ã»ó°úµµ ¿¬°áµÇ¾î ÀÖ´Ù. ±â¾ï°ú ÇнÀ µî¿¡ °ü¿©ÇÑ´Ù.
  • association center
    ¿¬ÇÕ ÁßÃß
  • association disturbance
    ¿¬»ó Àå¾Ö
  • association fiber
    ¿¬ÇÕ ¼¶À¯
  • chromosome association
    ¿°»öü Á¢ÇÕ
  • dental care councils of state dental association
    ÁÖ Ä¡°úÀÇ»çÇùȸ
  • The Amirican Association of Oral andMaxillofacial Surgeons
    ¹Ì±¹ ±¸°­ ¹× ¾Ç¾È¸é¿Ü°úÇùȸ
  • blue
    Ǫ¸¥, û»ö
    1. ½ºÆåÆ®·³ÀÇ ÁÖ »ö±òÁß ÇϳªÀÎ Çϴûö. 2. û¸íÇÑ ÇÏ´ÃÀÇ »ö. 3. Ǫ¸¥ »ö±òÀÇ ¹°°¨.
  • blue blindness
    û»ö »ö¸Í
    û»öÀÇ Áö°¢ ½Äº°ÀÌ Àß ¾È µÇ´Â °Í.
  • blue mark
    û»ö Ç¥½Ã
  • blue nevus
    û»ö ¸ð¹Ý
  • blue sclera
    û»ö °ø¸·
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
lymphoid series The cells at various states in the development in lymphoid tissue of the mature lymphocytes, e.g., lymphoblasts, young lymphocytes, mature lymphocytes.
(05 Mar 2000)
lyotropic series <chemistry> A listing of anions and cations in order of their effect on protein solubility (tendency to cause salting out). Essentially a competition between the protein and the ion for water molecules for hydration.
(20 Mar 1998)
Venereal Disease Research Laboratory <microbiology> A blood test used to diagnose syphilis.
Read as nonreactive or negative if you do not have syphilis. The Venereal Disease Research Laboratory can also be positive is cases of leprosy, malaria, mononucleosis, lupus, hepatitis A and pregnancy.
Positive Venereal Disease Research Laboratory tests are usually followed up by a more specific test (FTA antibodies).
(12 Jan 1998)
Medical Research Council <organisation> A UK Government funded body to promote the balanced development of medical and related biological research in the United Kingdom.
It organises national clinical trials for the assessment of new treatment protocols for leukaemia and some of the related diseases.
(05 Jan 1998)
research Careful, a diligent search, a close searching, studious inquiry or examination.
(18 Nov 1997)
research, controlled The first controlled clinical research was probably done in 1875 by the british naval surgeon james lind who, on board the hms salisbury, gave sailors with scurvy either oranges or lemons or cider or vinegar or nutmeg (or another treatment) and after just six days discovered that the citrus-consuming sailors had recovered from scury, until then the scourge of extended sea voyages, while the sailors who had been given the other treatments remained uncured.
(12 Dec 1998)
research design A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.
(12 Dec 1998)
research personnel Those individuals engaged in research.
(12 Dec 1998)
research support Financial support of research activities.
(12 Dec 1998)
peer review, research The evaluation by experts of the quality and pertinence of research or research proposals of other experts in the same field. Peer review is used by editors in deciding which submissions warrant publication, by granting agencies to determine which proposals should be funded, and by academic institutions in tenure decisions.
(12 Dec 1998)
clinical nursing research Research carried out by nurses in the clinical setting and designed to provide information that will help improve patient care. Other professional staff may also participate in the research.
(12 Dec 1998)
clinical research trials Evaluating the safety and effectiveness of medications or medical devices by monitoring their effects on large groups of people. Clinical medical trials sponsored by the U. S. Government are listed on a web site of the National Institutes of Health (NIH). The NIH Clinical Centre intends to make details of current clinical research studies for various diseases available over the Internet to increase opportunities for patients and physicians to participate in clinical investigations.
(12 Dec 1998)
controlled thermonuclear research General label for research on controlled thermonuclear fusion reactions.
(09 Oct 1997)
health outcomes research The measurement of the value of a particular course of therapy. Health outcomes research is based on the principle that every clinical intervention produces a change in the health status of a patient and that change can be measured.
(12 Dec 1998)
health services research The integration of epidemiologic, sociological, economic, and other analytic sciences in the study of health services. Health services research is usually concerned with relationships between need, demand, supply, use, and outcome of health services. The aim of the research is evaluation, particularly in terms of structure, process, output, and outcome.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • International Workingmen's Association
    ±¹Á¦ ³ëµ¿ÀÚ µ¿¸Í(º°ÄªFirst INTERNATIONAL)
  • association
    ¿¬ÇÕ;ÇÕµ¿;°áÇÕ;Á¶ÇÕ;¿¬»ó;°ü³ä¿¬ÇÕ;±³Á¦;Ä£¹Ð
  • association football
    Ã౸;»çÄ¿(soccer)
  • european free trade association
    À¯·´ÀÚÀ¯¹«¿ª¿¬ÇÕ
  • fraternal association
    ¿ì¾Ö Á¶ÇÕ
  • free association
    ÀÚÀ¯ ¿¬»ó(¹ý)
  • housing association
    (°øµ¿)ÁÖÅà °ÇÃà(±¸ÀÔ) Á¶ÇÕ
  • paren teacher association
    »çģȸ
  • press association
    =NEWS AGENCY;½Å¹®¹ßÇàÀÎ Çùȸ
  • purchasing association
    ±¸¸Å Á¶ÇÕ
  • research
    ¿¬±¸
  • listener research
    Àαâ ÇÁ·ÎÁ¶»ç
  • market research
    (Á¦Ç°À» ¸ÅÃâÇϱâ ÀüÀÇ) ½ÃÀå Á¶»ç
  • market research
    ½ÃÀå Á¶»ç (¾î¶² »óǰÀÇ ¼ö¿ä¸¦ À§ÇÑ »çÀü Á¶»ç)
  • marketing research
    ½ÃÀå Á¶»ç;½ÃÀå ºÐ¼®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á